Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Share-based Compensation (2017 - 2025)

Neuronetics (STIM) has disclosed Share-based Compensation for 9 consecutive years, with $2.2 million as the latest value for Q4 2025.

  • Quarterly Share-based Compensation rose 70.12% to $2.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.8 million through Dec 2025, up 22.24% year-over-year, with the annual reading at $6.8 million for FY2025, 22.24% up from the prior year.
  • Share-based Compensation for Q4 2025 was $2.2 million at Neuronetics, up from $1.4 million in the prior quarter.
  • The five-year high for Share-based Compensation was $2.3 million in Q1 2022, with the low at $1.3 million in Q4 2024.
  • Average Share-based Compensation over 5 years is $1.8 million, with a median of $1.8 million recorded in 2023.
  • The sharpest move saw Share-based Compensation skyrocketed 210.99% in 2021, then fell 25.87% in 2024.
  • Over 5 years, Share-based Compensation stood at $1.7 million in 2021, then grew by 24.08% to $2.1 million in 2022, then fell by 23.05% to $1.6 million in 2023, then dropped by 21.16% to $1.3 million in 2024, then skyrocketed by 70.12% to $2.2 million in 2025.
  • According to Business Quant data, Share-based Compensation over the past three periods came in at $2.2 million, $1.4 million, and $1.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.